Does DABIGATRAN ETEXILATE Cause Joint swelling? 103 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Joint swelling have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.3% of all adverse event reports for DABIGATRAN ETEXILATE.
103
Reports of Joint swelling with DABIGATRAN ETEXILATE
0.3%
of all DABIGATRAN ETEXILATE reports
0
Deaths
36
Hospitalizations
How Dangerous Is Joint swelling From DABIGATRAN ETEXILATE?
Of the 103 reports, 36 (35.0%) required hospitalization.
Is Joint swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Joint swelling?
ETANERCEPT (18,462)
ABATACEPT (18,453)
ADALIMUMAB (18,266)
METHOTREXATE (17,657)
TOCILIZUMAB (14,831)
LEFLUNOMIDE (13,026)
HYDROXYCHLOROQUINE (11,353)
RITUXIMAB (11,170)
TOFACITINIB (10,686)
INFLIXIMAB (9,853)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Joint swelling Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB